AABB is urging hospitals to remain highly vigilant in managing their blood inventories, especially type O negative red blood cells and AB plasma, as these products are in short supply this summer. AABB recommends hospitals reserve AB plasma for blood group AB patients with definitive transfusion needs. For situations where type O negative red blood cells and AB plasma are used as part of a massive transfusion protocol for patients of unknown blood type, every effort should be made to obtain a blood type for the patient as soon as possible. “Maintaining a safe and adequate blood supply is critical to the nation’s public health and a priority for the medical community,” said Miriam A. Markowitz, CEO of AABB. Hospitals are urged to follow available clinical practice guidelines for the appropriate use of individual blood products. AHA and AABB collaborated on a toolkit to assist hospitals as they implement a patient blood management approach as a component of their care planning decisions. 

Related News Articles

Headline
The House July 3 voted 218-214 to pass the final version of the One Big Beautiful Bill Act (H.R. 1), which enacts many of President Trump’s legislative…
Headline
The AHA July 3 released the Health Care Plan Accountability Update for the second quarter of 2025. The update covers the latest developments in Medicare…
Headline
The Food and Drug Administration yesterday released a safety notice announcing a software patch is available to address cybersecurity vulnerabilities in…
Headline
The House has begun consideration of the Senate-passed version of the One Big Beautiful Bill Act (H.R. 1). This continues to be a fluid…
Headline
The Departments of Justice and Health and Human Services today announced the creation of the DOJ-HHS False Claims Act Working Group to combat health care fraud…
Headline
Jon Ulven, Ph.D., behavioral health psychologist and chair of adult psychology at Sanford Health, details the fragile behavioral health landscape in rural…